x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Indiana
|
35-0225010
|
|||
(State
or other jurisdiction of incorporation or organization)
|
(IRS
Employer Identification Number)
|
905
West Boulevard North, Elkhart, IN
|
46514
|
|||
(Address
of principal executive offices)
|
(Zip
Code)
|
Page
|
|||
Item
1.
|
3
|
||
3
|
|||
- For the Three Months Ended March 29, 2009 and March 30,
2008
|
|||
4
|
|||
- As of March 29, 2009 and December 31, 2008
|
|||
5
|
|||
- For the Three Months Ended March 29, 2009 and March 30,
2008
|
|||
6
|
|||
- For the Three Months Ended March 29, 2009 and March 30,
2008
|
|||
7
|
|||
Item
2.
|
20
|
||
Item
3.
|
26
|
||
Item
4.
|
26
|
||
Item
1.
|
26
|
||
Item
1A.
|
27
|
||
Item
2.
|
27
|
||
Item
6.
|
27
|
||
28
|
Item
1. Financial
Statements
|
Three
Months Ended
|
||||||||
March
29,
2009
|
March 30,
2008*
|
|||||||
|
||||||||
Net
sales
|
$ | 118,131 | $ | 172,755 | ||||
Costs
and expenses:
|
||||||||
Cost
of goods sold
|
98,302 | 138,931 | ||||||
Selling,
general, and administrative expenses
|
16,620 | 20,976 | ||||||
Research
and development expenses
|
3,353 | 4,317 | ||||||
Restructuring
charge – Note I
|
2,243 | 150 | ||||||
Goodwill
impairment – Note J
|
33,153 | — | ||||||
Operating
(loss)/earnings
|
(35,540 | ) | 8,381 | |||||
Other
(expense)/income:
|
||||||||
Interest
expense – Note E
|
(888 | ) | (1,678 | ) | ||||
Interest
income
|
70 | 478 | ||||||
Other
|
(321 | ) | 747 | |||||
Total
other expense
|
(1,139 | ) | (453 | ) | ||||
(Loss)/earnings before
income taxes
|
(36,679 | ) | 7,928 | |||||
Income
tax (benefit)/expense
|
(1,030 | ) | 1,631 | |||||
Net
(loss)/earnings
|
$ | (35,649 | ) | $ | 6,297 | |||
Net
(loss)/earnings per share - Note K
|
||||||||
Basic
|
$ | (1.06 | ) | $ | 0.19 | |||
Diluted
|
$ | (1.06 | ) | $ | 0.18 | |||
Cash
dividends declared per share
|
$ | 0.03 | $ | 0.03 | ||||
Average
common shares outstanding:
|
||||||||
Basic
|
33,744 | 33,845 | ||||||
Diluted
|
33,744 | 38,335 |
March
29,
2009
|
December
31, 2008*
|
|||||||
ASSETS
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$
|
44,622
|
$
|
44,628
|
||||
Accounts
receivable, less allowances (2009 - $2,327; 2008 - $2,165)
|
76,661
|
94,175
|
||||||
Inventories,
net – Note
D
|
70,218
|
70,867
|
||||||
Other
current assets
|
17,285
|
16,172
|
||||||
Total
current assets
|
208,786
|
225,842
|
||||||
Property,
plant and equipment, less accumulated depreciation (2009 - $258,209;
2008 - $257,850)
|
87,728
|
90,756
|
||||||
Other
Assets
|
||||||||
Prepaid
pension asset
|
20,707
|
18,756
|
||||||
Goodwill
– Note J
|
—
|
33,150
|
||||||
Other
intangible assets – Note J
|
36,020
|
36,927
|
||||||
Deferred
income taxes
|
81,528
|
82,101
|
||||||
Other
|
891
|
910
|
||||||
Total
other assets
|
139,146
|
171,844
|
||||||
Total
Assets
|
$
|
435,660
|
$
|
488,442
|
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
||||||||
Current
Liabilities
|
||||||||
Notes
payable
|
$
|
197
|
$
|
—
|
||||
Accounts
payable
|
53,428
|
71,285
|
||||||
Accrued
liabilities
|
36,402
|
41,956
|
||||||
Total
current liabilities
|
90,027
|
113,241
|
||||||
Long-term
debt – Note
E
|
85,864
|
79,988
|
||||||
Other
long-term obligations
|
17,201
|
17,740
|
||||||
Shareholders’
Equity
|
||||||||
Preferred
stock - authorized 25,000,000 shares without par value; none
issued
|
—
|
—
|
||||||
Common
stock - authorized 75,000,000 shares without par value; 54,068,522 shares
issued at
March 29, 2009 and
54,031,844 shares
issued at
December 31, 2008
|
280,505
|
280,266
|
||||||
Additional
contributed capital
|
37,823
|
37,148
|
||||||
Retained
earnings
|
319,033
|
355,694
|
||||||
Accumulated
other comprehensive loss
|
(97,784
|
)
|
(98,626
|
)
|
||||
539,577
|
574,482
|
|||||||
Cost
of common stock held in treasury (2009 and 2008 – 20,320,759
shares)
|
(297,009
|
)
|
(297,009
|
)
|
||||
Total
shareholders’ equity
|
242,568
|
277,473
|
||||||
Total
Liabilities and Shareholders’ Equity
|
$
|
435,660
|
$
|
488,442
|
||||
*The Balance Sheet at
December 31, 2008 was adjusted from the previously filed 10-K to comply
with the provisions of FASB Staff Position No. APB 14-1,“Accounting for
Convertible Debt Instruments That May Be Settled in Cash upon Conversion
(Including Partial Cash Settlement)”.
See
notes to unaudited condensed consolidated financial
statements.
|
Three
Months Ended
|
||||||||
March
29,
2009
|
March
30,
2008*
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
(loss)/earnings
|
$
|
(35,649
|
)
|
$
|
6,297
|
|||
Adjustments
to reconcile net (loss)/earnings to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization
|
5,265
|
6,039
|
||||||
Prepaid
pension asset – Note F
|
(1,951
|
)
|
(2,420
|
)
|
||||
Equity-based
compensation – Note B
|
943
|
872
|
||||||
Restructuring
and impairment charges – Note I
|
2,243
|
55
|
||||||
Goodwill
impairment – Note J
|
33,153
|
—
|
||||||
(Gain)/loss
on sales of assets
|
(47
|
)
|
2
|
|||||
Amortization
of retirement benefit adjustments – Note F
|
1,322
|
540
|
||||||
Changes
in assets and liabilities, net of acquisitions
|
||||||||
Accounts
receivable
|
17,326
|
(3,537
|
)
|
|||||
Inventories
|
315
|
(823
|
)
|
|||||
Other
current assets
|
(1,732
|
)
|
(255
|
)
|
||||
Accounts
payable and accrued liabilities
|
(25,157
|
)
|
(13,911
|
)
|
||||
Other
|
(33
|
)
|
1,674
|
|||||
Total
adjustments
|
31,647
|
(11,764
|
)
|
|||||
Net
cash used in operating activities
|
(4,002
|
)
|
(5,467
|
)
|
||||
Cash
flows from investing activities:
|
||||||||
Payments
for acquisitions, net of cash received – Note C
|
—
|
(20,606
|
)
|
|||||
Capital
expenditures
|
(1,425
|
)
|
(3,488
|
)
|
||||
Proceeds
from sales of assets
|
198
|
—
|
||||||
Net
cash used in investing activities
|
(1,227
|
)
|
(24,094
|
)
|
||||
Cash
flows from financing activities:
|
||||||||
Payments
of long-term debt – Note E
|
(615,800
|
)
|
(223,300
|
)
|
||||
Proceeds
from borrowings of long-term debt – Note E
|
621,300
|
268,000
|
||||||
Payments
of short-term notes payable
|
(4,672
|
)
|
(2,961
|
)
|
||||
Proceeds
from borrowings of short-term notes payable
|
4,869
|
1,961
|
||||||
Dividends
paid
|
(1,012
|
)
|
(1,010
|
)
|
||||
Other
|
(17
|
)
|
(6,814
|
)
|
||||
Net
cash provided by financing activities
|
4,668
|
35,876
|
||||||
Effect
of exchange rate on cash and cash equivalents
|
555
|
164
|
||||||
Net
(decrease)/increase in cash and cash equivalents
|
(6
|
)
|
6,479
|
|||||
Cash
and cash equivalents at beginning of year
|
44,628
|
52,868
|
||||||
Cash
and cash equivalents at end of period
|
$
|
44,622
|
$
|
59,347
|
||||
Supplemental
cash flow information
|
||||||||
Cash
paid during the period for:
|
||||||||
Interest
|
$
|
271
|
$
|
528
|
||||
Income
taxes—net
|
$
|
1,946
|
$
|
255
|
||||
Three
Months Ended
|
||||||||
March
29,
2009
|
March
30,
2008*
|
|||||||
Net
(loss)/earnings
|
$
|
(35,649
|
)
|
$
|
6,297
|
|||
Other
comprehensive earnings:
|
||||||||
Cumulative
translation adjustment
|
28
|
173
|
||||||
Amortization of
retirement benefit adjustments (net of tax)
|
814
|
244
|
||||||
Comprehensive
(loss)/earnings
|
$
|
(34,807
|
)
|
$
|
6,714
|
($
in thousands)
|
March
29,
2009
|
March
30,
2008
|
||||||
Stock
options
|
$ | 19 | $ | 49 | ||||
Restricted
stock units
|
924 | 804 | ||||||
Restricted
stock
|
— | 20 | ||||||
Total
|
$ | 943 | $ | 873 |
2004
Plan
|
2001
Plan
|
1996
Plan
|
||||||||||
Awards
originally available
|
6,500,000
|
2,000,000
|
1,200,000
|
|||||||||
Stock
options outstanding
|
313,850
|
743,863
|
227,050
|
|||||||||
Restricted
stock units outstanding
|
660,958
|
—
|
—
|
|||||||||
Awards
exercisable
|
239,325
|
743,863
|
227,050
|
|||||||||
Awards
available for grant
|
5,080,431
|
—
|
—
|
March
29, 2009
|
March
30, 2008
|
|||||||||||||||
Options
|
Weighted-Average
Exercise
Price
|
Options
|
Weighted-Average
Exercise
Price
|
|||||||||||||
Outstanding
at beginning of year
|
1,294,263 | $ | 14.53 | 1,426,638 | $ | 16.06 | ||||||||||
Granted
|
— | — | — | — | ||||||||||||
Exercised
|
— | — | (2,000 | ) | 8.22 | |||||||||||
Expired
|
(9,500 | ) | 22.38 | (98,250 | ) | 34.30 | ||||||||||
Forfeited
|
— | — | — | — | ||||||||||||
Outstanding
at end of period
|
1,284,763 | $ | 14.47 | 1,326,388 | $ | 14.72 | ||||||||||
Exercisable
at end of period
|
1,210,238 | $ | 14.59 | 1,173,401 | $ | 15.05 |
Weighted-average
Remaining
Contractual
Life
|
Aggregate
Intrinsic
Value
|
||||
Options
outstanding
|
3.7
years
|
$
|
—
|
||
Options
exercisable
|
3.5
years
|
—
|
March
29, 2009
|
March
30, 2008
|
|||||||||||||||
Options
|
Weighted-average
Grant-Date
Fair
Value
|
Options
|
Weighted-average
Grant-Date
Fair
Value
|
|||||||||||||
Nonvested
at beginning of year
|
74,525 | $ | 12.54 | 158,587 | $ | 6.41 | ||||||||||
Granted
|
— | — | — | — | ||||||||||||
Vested
|
— | — | (5,600 | ) | 8.31 | |||||||||||
Forfeited
|
— | — | — | — | ||||||||||||
Nonvested
at end of period (1)
|
74,525 | $ | 12.54 | 152,987 | $ | 6.34 |
Options
Outstanding
|
Options
Exercisable
|
||||||||||||||||||||
Weighted
Average
|
|||||||||||||||||||||
Range
of
|
Number
|
Remaining
|
Weighted
Average
|
Number
|
Weighted
Average
|
||||||||||||||||
Exercise
|
Outstanding
|
Contractual
|
Exercise
|
Exercisable
|
Exercise
|
||||||||||||||||
Prices
|
at
3/29/09
|
Life
(Years)
|
Price
|
At
3/29/09
|
Price
|
||||||||||||||||
$
|
7.70
– 11.11
|
778,763
|
4.41
|
$
|
9.44
|
745,738
|
$
|
9.37
|
|||||||||||||
13.68
– 16.24
|
227,800
|
4.49
|
14.12
|
186,300
|
14.22
|
||||||||||||||||
23.00
– 33.63
|
231,950
|
1.79
|
24.77
|
231,950
|
24.77
|
||||||||||||||||
35.97
– 79.25
|
46,250
|
1.12
|
49.20
|
46,250
|
49.20
|
March
29, 2009
|
March
30, 2008
|
|||||||||||||||
RSUs
|
Weighted-average
Grant-Date
Fair
Value
|
RSUs
|
Weighted-average
Grant-Date
Fair
Value
|
|||||||||||||
Outstanding
at beginning of year
|
700,358 | $ | 10.76 | 595,148 | $ | 12.14 | ||||||||||
Granted
|
6,000 | 5.26 | 26,000 | 10.62 | ||||||||||||
Converted
|
(38,950 | ) | 6.47 | (10,430 | ) | 10.89 | ||||||||||
Forfeited
|
(6,450 | ) | 12.11 | (9,810 | ) | 12.33 | ||||||||||
Outstanding
at end of period
|
660,958 | $ | 10.95 | 600,908 | $ | 12.10 | ||||||||||
Weighted-average
remaining contractual life
|
5.5
years
|
5.0
years
|
·
|
Tusonix,
Inc. (“Tusonix”), based in Tucson, Arizona, a leader in the design and
manufacture of ceramic electromagnetic interference and radio frequency
interference (“EMI/RFI”) filters;
and
|
·
|
Orion
Manufacturing, Inc. (“Orion”), based in San Jose, California, a contract
electronics manufacturer.
|
($
in thousands)
|
March
29,
2009
|
December
31,
2008
|
||||||
Finished
goods
|
$
|
10,139
|
$
|
7,813
|
||||
Work-in-process
|
17,469
|
16,246
|
||||||
Raw
materials
|
42,610
|
46,808
|
||||||
Total
inventories, net
|
$
|
70,218
|
$
|
70,867
|
($
in thousands)
|
March
29,
2009
|
December
31,
2008
|
||||||
Revolving
credit agreement, weighted-average interest rate of 1.2% (2009), and 4.2%
(2008)
due in 2011
|
$ | 53,500 | 48,000 | |||||
Convertible,
senior subordinated debentures at an effective interest rate of 7.0% and a
coupon
rate of 2.1%,
due in 2024, net
of discount of $136
and $512
|
32,364 | 31,988 | ||||||
Total
long-term debt
|
$ | 85,864 | 79,988 |
Three
months ended March 30, 2008
|
||||||||||||
($
in thousands)
|
As
originally reported
|
As
adjusted
|
Effect
of change in accounting principle
|
|||||||||
Interest
expense
|
$
|
1,059
|
$
|
1,678
|
$
|
619
|
||||||
Tax
expense
|
1,881
|
1,631
|
(250
|
)
|
||||||||
Net
Earnings
|
6,666
|
6,297
|
(369
|
)
|
||||||||
Earnings
per share-basic
|
0.20
|
0.19
|
(0.01
|
)
|
||||||||
Earnings
per share-fully diluted
|
0.18
|
0.18
|
—
|
Pension
Plans
|
Other
Postretirement
Benefit
Plans
|
|||||||||||||||
($ in
thousands)
|
March 29, 2009
|
March 30,
2008
|
March 29,
2009
|
March 30,
2008
|
||||||||||||
Service
cost
|
$ | 779 | $ | 887 | $ | 3 | $ | 5 | ||||||||
Interest
cost
|
3,432 | 3,297 | 78 | 92 | ||||||||||||
Expected
return on plan assets (1)
|
(6,096 | ) | (6,597 | ) | — | — | ||||||||||
Amortization
of prior service cost
|
126 | 135 | — | — | ||||||||||||
Amortization
of loss/(gain)
|
1,221 | 429 | (25 | ) | — | |||||||||||
(Income)/expense,
net
|
$ | (538 | ) | $ | (1,849 | ) | $ | 56 | $ | 97 |
($
in thousands)
|
EMS
|
Components and
Sensors
|
Total
|
|||||||||
First
Quarter of 2009
|
||||||||||||
Net
sales to external customers
|
$ | 75,822 | $ | 42,309 | $ | 118,131 | ||||||
Segment
operating (loss)/earnings
|
3,264 | (3,408 | ) | (144 | ) | |||||||
Total
assets
|
139,597 | 296,063 | 435,660 | |||||||||
First
Quarter of 2008
|
||||||||||||
Net
sales to external customers
|
$ | 94,968 | $ | 77,787 | $ | 172,755 | ||||||
Segment
operating earnings
|
2,030 | 6,775 | 8,805 | |||||||||
Total
assets
|
187,642 | 394,602 | 582,244 |
($
in thousands)
|
First
Quarter
2009
|
First
Quarter
2008
|
||||||
Total
segment operating (loss)/earnings
|
$ | (144 | ) | $ | 8,805 | |||
Restructuring
and restructuring-related charges
|
(2,243 | ) | (424 | ) | ||||
Goodwill
impairment
|
(33,153 | ) | — | |||||
Interest
expense
|
(888 | ) | (1,678 | ) | ||||
Interest
income
|
70 | 478 | ||||||
Other
(expense)/income
|
(321 | ) | 747 | |||||
(Loss)/earnings
before income taxes
|
$ | (36,679 | ) | $ | 7,928 |
($ in
millions)
November 2007 Plan
|
Planned
Costs
|
Actual incurred
through
December
31, 2008
|
||||||
|
|
|||||||
Workforce
reduction
|
$ | 1.7 | $ | 1.5 | ||||
Asset
impairments
|
0.9 | 1.2 | ||||||
Restructuring
charge
|
2.6 | 2.7 | ||||||
Equipment
relocation
|
0.2 | 0.1 | ||||||
Other
costs
|
0.2 | 0.4 | ||||||
Restructuring-related
costs
|
0.4 | 0.5 | ||||||
Total
restructuring and restructuring-related costs
|
$ | 3.0 | $ | 3.2 |
($ in
millions)
September 2008 Plan
|
Planned
Costs
|
Actual
incurred
through
December
31, 2008
|
||||||
|
|
|||||||
Workforce
reduction
|
$ | 2.4 | $ | 3.9 | ||||
Asset
impairments
|
1.1 | 1.2 | ||||||
Other
charges
|
0.2 | 0.1 | ||||||
Restructuring
charge
|
3.7 | 5.2 | ||||||
Equipment
and employee relocation
|
0.2 | 0.1 | ||||||
Other
costs
|
0.5 | 0.2 | ||||||
Restructuring-related
costs
|
0.7 | 0.3 | ||||||
Total
restructuring and restructuring-related costs
|
$ | 4.4 | $ | 5.5 |
($ in
millions) September
2008 Plan
|
||||
Restructuring
liability at January 1, 2009
|
$
|
1.7
|
||
Restructuring
and restructuring-related charges, excluding asset impairments and
write-offs
|
—
|
|||
Cost
paid
|
(1.7
|
)
|
||
Restructuring
liability at March 29, 2009
|
$
|
—
|
($ in
millions) March
2009 Plan
|
Planned
Costs
|
Actual
incurred through
March
29, 2009
|
||||||
|
|
|||||||
Workforce
reduction
|
$ | 1.9 | $ | 2.1 | ||||
Asset
impairments
|
— | 0.1 | ||||||
Total
restructuring and impairment charge
|
$ | 1.9 | $ | 2.2 |
($
in millions) March 2009
Plan
|
||||
Restructuring
liability at January 1, 2009
|
$
|
—
|
||
Restructuring
and restructuring-related charges, excluding asset impairments and
write-offs
|
2.1
|
|||
Cost
paid
|
(0.4
|
)
|
||
Restructuring
liability at March 29, 2009
|
$
|
1.7
|
EMS
|
Components
& Sensors
|
Total
CTS
|
||||||||||
Balance
at January 1, 2008
|
24,144
|
513
|
24,657
|
|||||||||
Tusonix
acquisition
|
—
|
1,857
|
1,857
|
|||||||||
Orion
acquisition
|
6,636
|
—
|
6,636
|
|||||||||
Balance
at December 31, 2008
|
30,780
|
2,370
|
33,150
|
|||||||||
Purchase
accounting adjustment
|
—
|
3
|
3
|
|||||||||
Impairment
loss
|
(30,780
|
)
|
(2,373
|
)
|
(33,153
|
)
|
||||||
Balance
at March 29, 2009
|
—
|
—
|
—
|
March
29, 2009
|
December
31, 2008
|
|||||||||||||||
($
in thousands)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
||||||||||||
Amortized
intangible assets:
|
||||||||||||||||
Customer
lists/relationships
|
$
|
51,084
|
$
|
(15,663
|
)
|
$
|
51,084
|
$
|
(15,038
|
)
|
||||||
Patents
|
10,319
|
(10,154
|
)
|
10,319
|
(9,886
|
)
|
||||||||||
Other
intangibles
|
500
|
(66
|
)
|
500
|
(52
|
)
|
||||||||||
Total
|
61,903
|
(25,883
|
)
|
61,903
|
(24,976
|
)
|
||||||||||
Goodwill
|
—
|
—
|
33,150
|
—
|
||||||||||||
Total
other intangible assets and goodwill
|
$
|
61,903
|
$
|
(25,883
|
)
|
$
|
95,053
|
$
|
(24,976
|
)
|
($
in thousands, except per share amounts)
|
Net
Earnings (Numerator)
|
Shares
(in
thousands) (Denominator)
|
Per Share
Amount
|
|||||||||
First
Quarter 2009
|
||||||||||||
Basic
loss per share
|
$ | (35,649 | ) | 33,744 | $ | (1.06 | ) | |||||
Effect
of dilutive securities:
|
||||||||||||
Convertible
debt
|
— | — | ||||||||||
Equity-based
compensation plans
|
— | — | ||||||||||
Diluted
loss per share
|
$ | (35,649 | ) | 33,744 |
$
|
(1.06 | ) | |||||
First
Quarter 2008
|
||||||||||||
Basic
EPS
|
$ | 6,297 | 33,845 | $ | 0.19 | |||||||
Effect
of dilutive securities:
|
||||||||||||
Convertible
debt
|
631 | 4,000 | ||||||||||
Equity-based
compensation plans
|
— | 490 | ||||||||||
Diluted
EPS
|
$ | 6,928 | 38,335 | $ | 0.18 |
Three
Months Ended
|
||||||||
(Number
of shares in thousands)
|
March
29,
2009
|
March 30,
2008
|
||||||
Stock
options where the assumed proceeds exceed the average market price of
common shares during the period
|
1,285 | 666 | ||||||
Restricted
Stock Units
|
495 | — | ||||||
Securities
related to the subordinated convertible debt
|
2,167 | — |
($
in thousands)
|
As
reported
|
Discrete item goodwill
impairment
|
Net loss before goodwill
impairment
|
|||||||||
Pre-tax
loss
|
$ | (36,679 | ) | $ | (33,153 | ) | $ | (3,526 | ) | |||
Tax
benefit
|
(1,030 | ) | (205 | ) | (825 | ) | ||||||
Net
loss
|
(35,649 | ) | (32,948 | ) | (2,701 | ) | ||||||
First
quarter 2009 effective tax rate as reported
|
2.8 | % | ||||||||||
Full
year 2009 tax rate excluding the discrete item
|
23.4 | % |
·
|
Total
sales in the first quarter 2009 of $118.1 million were reported through
two segments, EMS and Components and Sensors. Sales decreased
by $54.6 million, or 31.6%, in the first quarter of 2009 from the first
quarter of 2008. Sales in the Components and Sensors segment
decreased by 45.6% versus the first quarter of 2008, while sales in the
EMS segment decreased by 20.2% compared to the first quarter of
2008.
|
·
|
Gross
margins, as a percent of sales, were 16.8% and 19.6% in the first quarters
of 2009 and 2008, respectively. The Components and Sensors
segment, which inherently generates a higher gross margin, decreased to
35.8% of total company sales in the first quarter of 2009 compared to
45.0% of total sales in the same period of
2008.
|
·
|
Selling,
general and administrative (“SG&A”) and research and development
("R&D") expenses were $20.0 million in the first quarter of 2009
compared to $25.3 million in the first quarter of 2008. This
significant reduction reflects our proactive management of costs,
including restructuring actions cost-cutting measures and a greater than
$2.0 million decrease in discretionary
spending.
|
·
|
Interest
and other expense in the first quarter of 2009 was $1.1 million versus
$0.5 million in the same quarter of
2008.
|
·
|
The
effective tax rate for the first quarter of 2009 was 2.8%. This
rate includes a discrete period tax benefit of $0.2 million related to our
goodwill impairment. Excluding this discrete item the full year
tax rate is 23.4%. Refer to Note M, “Income Taxes”, for further
details.
|
·
|
Net
loss was $35.6 million, or $1.06 per diluted share, in the first quarter
of 2009, including $33.2 million, or $0.98 per diluted share, for non-cash
goodwill impairment and $2.2 million, or $0.05 per diluted share, of
restructuring charges. This compares with net
income of $6.3 million, or $0.18 per diluted share, in the first quarter
of 2008.
|
·
|
Inventory
valuation, the allowance for doubtful accounts, and other accrued
liabilities
|
·
|
Long-lived
and intangible assets valuation, and depreciation/amortization
periods
|
·
|
Income
taxes
|
·
|
Retirement
plans
|
·
|
Equity-based
compensation
|
($
in thousands)
|
Components
& Sensors
|
EMS
|
Consolidated
Total
|
|||||||||
First
Quarter 2009
|
||||||||||||
Sales
|
$
|
42,309
|
$
|
75,822
|
$
|
118,131
|
||||||
Segment
operating (loss)/earnings
|
(3,408
|
)
|
3,264
|
(144
|
)
|
|||||||
%
of sales
|
(8.1
|
)%
|
4.3
|
%
|
(0.1
|
)%
|
||||||
First
Quarter 2008
|
||||||||||||
Sales
|
$
|
77,787
|
$
|
94,968
|
$
|
172,755
|
||||||
Segment
operating earnings
|
6,775
|
2,030
|
8,805
|
|||||||||
%
of sales
|
8.7
|
%
|
2.1
|
%
|
5.1
|
%
|
Three
months ended
|
||||||||||||
($
in thousands, except net earnings per share)
|
March
29, 2009
|
March
30, 2008
|
Increase
(Decrease)
|
|||||||||
Net
sales
|
$
|
118,131
|
$
|
172,755
|
$
|
(54,624
|
)
|
|||||
Restructuring-related
costs
|
—
|
274
|
(274
|
)
|
||||||||
%
of net sales
|
—
|
%
|
0.2
|
%
|
(0.2
|
)%
|
||||||
Gross
margin
|
19,829
|
33,824
|
(13,995
|
)
|
||||||||
%
of net sales
|
16.8
|
%
|
19.6
|
%
|
(2.8
|
)%
|
||||||
Selling,
general and administrative expenses
|
16,620
|
20,976
|
(4,356
|
)
|
||||||||
%
of net sales
|
14.1
|
%
|
12.1
|
%
|
2.0
|
%
|
||||||
Research
and development expenses
|
3,353
|
4,317
|
(964
|
)
|
||||||||
%
of net sales
|
2.8
|
%
|
2.5
|
%
|
0.3
|
%
|
||||||
Restructuring
charge
|
2,243
|
150
|
2,093
|
|||||||||
%
of net sales
|
1.9
|
%
|
0.1
|
%
|
1.8
|
%
|
||||||
Goodwill
impairment
|
33,153
|
—
|
33,153
|
|||||||||
%
of net sales
|
28.1
|
%
|
—
|
%
|
28.1
|
%
|
||||||
Operating
earnings
|
(35,540
|
)
|
8,381
|
(43,921
|
)
|
|||||||
%
of net sales
|
(30.1
|
)%
|
4.9
|
%
|
(35.0
|
)%
|
||||||
Income
tax (benefit)/expense
|
(1,030
|
)
|
1,631
|
(2,661
|
)
|
|||||||
Net
earnings
|
(35,649
|
)
|
6,297
|
(41,946
|
)
|
|||||||
%
of net sales
|
(30.2
|
)%
|
3.6
|
%
|
(33.8
|
)%
|
||||||
Net
(loss)/earnings per diluted share
|
$
|
(1.06
|
)
|
$
|
0.18
|
$
|
(1.24
|
)
|
||||
Item
4. Controls and
Procedures
|
Item
1. Legal
Proceedings
|
(a)
Total Number
of Shares
Purchased
|
(b)
Average
Price
Paid
per Share
|
(c)
Total
Number
of
Shares
Purchased
as
Part of
Plans
or Programs
(1)
|
(d)
Maximum
Number
of
Shares
That
May
Yet
Be
Purchased
Under the
Plans
or Programs
|
|||||||||||||
977,500
|
||||||||||||||||
January
1, 2009 – March 29, 2009
|
—
|
—
|
—
|
977,500
|
||||||||||||
Total
|
—
|
$
|
—
|
—
|
|
_____________________________
|
(1)
|
In May 2008, CTS’ Board of
Directors authorized a program to repurchase up to one million shares of
its common stock in the open market. The authorization does not
expire.
|
2009
– 2010 Performance Restricted Stock Unit Plan
|
|
Certification
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
Certification
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
|
|
Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of
2002.
|
CTS
Corporation
|
CTS
Corporation
|
||
/s/
Richard G. Cutter III
|
/s/
Donna L. Belusar
|
||
Richard
G. Cutter III
Vice
President, Secretary and General Counsel
|
Donna
L. Belusar
Senior
Vice President and Chief Financial Officer
|
||
Dated: April 29, 2009 | Dated: April 29, 2009 |